Cancer Biomarkers Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 01
SKU : MD578
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Cancer Biomarker Market ?
Global Cancer Biomarker Market reached USD 13.2 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 32.5 billion by 2031.
Who are the key players in Cancer Biomarker Market ?
Major players are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, bioMérieux SA, Enzo Biochem, Inc., Merck Millipore and Micron Technology.
Related Reports
clinical-diagnosticsCardiac Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 March 23
Starting from
$4350
clinical-diagnosticsRenal Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 06
Starting from
$4350
pharmaceuticalsBiomarkers Market Size, Share, Industry, Forecast (2024-2031)
Published: 2024 January 16
Starting from
$4350
clinical-diagnosticsGenomic Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 24
Starting from
$4350
pharmaceuticalsProstate Cancer Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 06
Starting from
$4350
medical-devicesCancer Biopsies Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 16
Starting from
$4350